Further characterization and validation of gpt delta transgenic mice for quantifying somatic mutations in vivo

The utility of any mutation assay depends on its characteristics, which are best discovered using model mutagens. To this end, we report further on the characteristics of the lambda‐based gpt delta transgenic assay first described by Nohmi et al. ([1996]: Environ Mol Mutagen 28:465–470). Our studies show that the gpt transgene responds similarly to other transgenic loci, specifically lacZ and cII, after treatment with acute doses of N‐ethyl‐N‐nitrosourea (ENU). Because genetic neutrality is an important factor in the design of treatment protocols for mutagenicity testing, as well as for valid comparisons between different tissues and treatments, a time‐course study was conducted. The results indicate that the gpt transgene, like cII and lacZ, is genetically neutral in vivo. The sensitivities of the loci are also equivalent, as evidenced by spontaneous mutant frequency data and dose– response curves after acute treatment with 50, 150, or 250 mg/kg ENU. The results are interesting in light of transgenic target size and location and of host genetic background differences. Based on these studies, protocols developed for other transgenic assays should be suitable for the gpt delta. Additionally, a comparison of the gpt and an endogenous locus, Dlb‐1, within the small intestine of chronically treated animals (94 μg/mL ENU in drinking water daily) shows differential accumulation of mutations at the loci during chronic exposure. The results further support the existence of preferential repair at endogenous, expressed genes relative to transgenes. Environ. Mol. Mutagen. 37:297–303, 2001 © 2001 Wiley‐Liss, Inc.

[1]  J. Heddle,et al.  Differential mutation of transgenic and endogenous loci in vivo. , 2000, Mutation research.

[2]  N. Shima,et al.  Dietary restriction during murine development provides protection against MNU-induced mutations. , 2000, Mutation research.

[3]  T. Skopek,et al.  In vivo transgenic mutation assays , 2000, Environmental and molecular mutagenesis.

[4]  A. Yoshitake,et al.  Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector. , 1999, Mutation research.

[5]  J. Heddle,et al.  The relationship between mutant frequency and time in vivo: simple predictions for any tissue, cell type, or mutagen. , 1999, Mutation research.

[6]  J. Bielas,et al.  The cII locus in the Muta™Mouse System , 1999 .

[7]  O. Ueda,et al.  Spi− selection: An efficient method to detect γ‐ray‐induced deletions in transgenic mice , 1999, Environmental and molecular mutagenesis.

[8]  P. Harbach,et al.  Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue® transgenic mice , 1999, Environmental and Molecular Mutagenesis.

[9]  O. Ueda,et al.  Spectra of gpt mutations in ethylnitrosourea‐treated and untreated transgenic mice , 1999, Environmental and molecular mutagenesis.

[10]  T. Nohmi,et al.  Efficient detection of deletions induced by a single treatment of mitomycin C in transgenic mouse gpt delta using the Spi− selection , 1999, Environmental and molecular mutagenesis.

[11]  J. Heddle.  Mutant manifestation: the time factor in somatic mutagenesis. , 1999, Mutagenesis.

[12]  P. Harbach,et al.  Comparison of mutant frequencies at the transgenic lambda lacI and cII/cI loci in control and ENU‐treated Big Blue® mice , 1999, Environmental and molecular mutagenesis.

[13]  J. Heddle,et al.  Effects of extended chronic exposures on endogenous and transgenic loci: Implications for low‐dose extrapolations , 1999, Environmental and molecular mutagenesis.

[14]  J. Heddle,et al.  A comparison of the effects of diverse mutagens at the lacZ transgene and Dlb-1 locus in vivo. , 1999, Mutagenesis.

[15]  T. Skopek,et al.  A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice. , 1998, Mutation research.

[16]  R. Mittelstaedt,et al.  Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats. , 1998, Mutation research.

[17]  D. Casciano,et al.  Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue(R) rats treated with 7, 12-dimethylbenz[a]anthracene. , 1998, Mutation research.

[18]  E. Fearon.  Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.

[19]  H. Heng,et al.  Identical megabase transgenes on mouse chromosomes 3 and 4 do not promote ectopic pairing or synapsis at meiosis. , 1997, Genome.

[20]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[21]  J. Heddle,et al.  Risk estimation from somatic mutation assays. , 1996, Mutation research.

[22]  J. French,et al.  Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Glazer,et al.  Other transgenic mutation assays: Tissue specificity of spontaneous point mutations in λsupF transgenic mice , 1996 .

[24]  T. Skopek,et al.  System Issues: Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene‐treated Big Blue™ B6C3F1 mice , 1996 .

[25]  J. Heddle,et al.  System issues: A test for neutrality of mutations of the lacZ transgene , 1996, Environmental and molecular mutagenesis.

[26]  G. Douglas,et al.  System issues: Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice , 1996, Environmental and molecular mutagenesis.

[27]  O. Ueda,et al.  Other transgenic mutation assays: A new transgenic mouse mutagenesis test system using Spi− and 6‐thioguanine selections , 1996, Environmental and molecular mutagenesis.

[28]  P. Glazer,et al.  Frequent spontaneous deletions at a shuttle vector locus in transgenic mice. , 1996, Mutagenesis.

[29]  J. Heddle,et al.  Enhanced somatic mutation rates induced in stem cells of mice by low chronic exposure to ethylnitrosourea. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Heddle,et al.  Treatment protocols for transgenic mutation assays in vivo. , 1995, Mutagenesis.

[31]  J. Heddle,et al.  Factors affecting somatic mutation frequencies in vivo. , 1995, Mutation research.

[32]  J. Tucker,et al.  The transmission rate of the lacI transgene from the Big Blue mouse. , 1995, Mutation research.

[33]  T. Skopek.  Of mice and mutants: target size and sensitivity. , 1995, Mutation research.

[34]  T R Skopek,et al.  Relative sensitivity of the endogenous hprt gene and lacl transgene in ENU‐treated big blue™ B6C3F1 mice , 1995, Environmental and molecular mutagenesis.

[35]  J. Vijg,et al.  LacZ transgenic mouse models: their application in genetic toxicology. , 1994, Mutation research.

[36]  S. Dean,et al.  Measurement of gene mutation in vivo using Muta Mouse and positive selection for lacZ- phage. , 1994, Mutagenesis.

[37]  J. Heddle,et al.  The accumulation and persistence of somatic mutations in vivo. , 1994, Mutagenesis.

[38]  J. Mirsalis,et al.  Transgenic animal models for measuring mutations in vivo. , 1994, Critical reviews in toxicology.

[39]  J. Heddle,et al.  Comparison of somatic mutation in a transgenic versus host locus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B. Burkhart,et al.  ENU-induced mutagenesis at a single A: T base pair in transgenic mice containing phi X174. , 1993, Mutation research.

[41]  J. T. Macgregor,et al.  Induction of hepatic mutations in lacI transgenic mice. , 1993, Mutagenesis.

[42]  J. Short,et al.  The use of selection in recovery of transgenic targets for mutation analysis. , 1993, Mutation research.

[43]  J. Vijg,et al.  High somatic mutation frequencies in a LacZ transgene integrated on the mouse X-chromosome. , 1991, Mutation research.

[44]  Jeffrey H. Miller.  Bacterial genetic systems , 1991 .

[45]  J. Short,et al.  Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacl shuttle vector , 1991, Environmental and molecular mutagenesis.

[46]  B. Myhr.  Validation studies with Muta™ mouse: A transgenic mouse model for detecting mutations in vivo , 1991, Environmental and molecular mutagenesis.

[47]  J Vijg,et al.  Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[48]  B. A. J. Ponder,et al.  A clonal marker induced by mutation in mouse intestinal epithelium , 1988, Nature.

[49]  C. O. Doudney.  Deoxyribonucleic acid replication in UV-damaged bacteria revisited. , 1971, Mutation research.